- Home
- INLX vs LSB Comparison
INLX vs LSB Comparison
Compare INLX & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLX
- LSB
- Stock Information
- Founded
- INLX 1996
- LSB 2002
- Country
- INLX United States
- LSB China
- Employees
- INLX 199
- LSB N/A
- Industry
- INLX EDP Services
- LSB
- Sector
- INLX Technology
- LSB
- Exchange
- INLX Nasdaq
- LSB NYSE
- Market Cap
- INLX 59.0M
- LSB 49.8M
- IPO Year
- INLX N/A
- LSB N/A
- Fundamental
- Price
- INLX $13.75
- LSB $2.60
- Analyst Decision
- INLX
- LSB
- Analyst Count
- INLX 0
- LSB 0
- Target Price
- INLX N/A
- LSB N/A
- AVG Volume (30 Days)
- INLX 4.3K
- LSB 15.7K
- Earning Date
- INLX 11-13-2024
- LSB 01-21-2025
- Dividend Yield
- INLX N/A
- LSB N/A
- EPS Growth
- INLX N/A
- LSB N/A
- EPS
- INLX N/A
- LSB N/A
- Revenue
- INLX $17,930,991.00
- LSB $79,415,311.00
- Revenue This Year
- INLX $9.27
- LSB $39.33
- Revenue Next Year
- INLX $8.10
- LSB $75.61
- P/E Ratio
- INLX N/A
- LSB N/A
- Revenue Growth
- INLX 7.17
- LSB N/A
- 52 Week Low
- INLX $4.52
- LSB $1.88
- 52 Week High
- INLX $16.50
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- INLX 49.53
- LSB 44.96
- Support Level
- INLX $13.49
- LSB $2.10
- Resistance Level
- INLX $14.38
- LSB $2.77
- Average True Range (ATR)
- INLX 0.57
- LSB 0.36
- MACD
- INLX -0.07
- LSB 0.01
- Stochastic Oscillator
- INLX 47.96
- LSB 34.68
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.